A Study to Describe the Characteristics, Health Care Interventions and Outcomes of Patients With Major Bleedings in the Presence of Factor Xa Inhibitor Treatment

CompletedOBSERVATIONAL
Enrollment

2,219

Participants

Timeline

Start Date

December 4, 2023

Primary Completion Date

November 29, 2024

Study Completion Date

November 29, 2024

Conditions
Major Bleeding
Interventions
OTHER

None (Observational study)

Not Applicable since Observational Study

Trial Locations (75)

10305

Research Site, Staten Island

10595

Research Site, Valhalla

11040

Research Site, New Hyde Park

11794

Research Site, Stony Brook

12208

Research Site, Albany

27514

Research Site, Chapel Hill

32803

Research Site, Orlando

33606

Research Site, Tampa

40536

Research Site, Lexington

43210

Research Site, Columbus

43614

Research Site, Toledo

48073

Research Site, Royal Oak

53226

Research Site, Milwaukee

60026

Research Site, Glenview

63110

Research Site, St Louis

64111

Research Site, Kansas City

66160

Research Site, Kansas City

75390

Research Site, Dallas

85224

Research Site, Chandler

90509

Research Site, Torrance

92868

Research Site, Orange

95817

Research Site, Sacramento

80228-1527

Research Site, Lakewood

06102

Research Site, Hartford

97201-3098

Research Site, Portland

Unknown

Research Site, Aachen

Research Site, Altenburg

Research Site, Bad Neustadt/Saale

Research Site, Berlin

Research Site, Bochum

Research Site, Bonn

Research Site, Cologne

Research Site, Dortmund

Research Site, Dresden

Research Site, Essen

Research Site, G Ppingen

Research Site, Jena

Research Site, Koblenz

Research Site, L Beck

Research Site, L Neburg

Research Site, Leipzig

Research Site, Ludwigshafen am Rhein

Research Site, Osnabr Ck

Research Site, Potsdam

Research Site, Trier

Research Site, Tübingen

Research Site, Würzburg

Research Site, Asahikawa

Research Site, Fukuoka

Research Site, Hitachi

Research Site, Izumo

Research Site, Kagoshima

Research Site, Kamakura

Research Site, Kitakyushu

Research Site, Kyoto

Research Site, Mitaka

Research Site, Nagakute

Research Site, Okayama

Research Site, Saga

Research Site, Shimotsuke

Research Site, Suita

Research Site, Tachikawa

Research Site, Tokyo

Research Site, Aberdeen

Research Site, Bournemouth

Research Site, Canterbury

Research Site, Cardiff

Research Site, Edgbaston

Research Site, Harrow

Research Site, Liverpool

Research Site, London

Research Site, Oxford

Research Site, Preston

Research Site, Sheffield

Research Site, Southampton

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Parexel

INDUSTRY

lead

AstraZeneca

INDUSTRY

NCT06147830 - A Study to Describe the Characteristics, Health Care Interventions and Outcomes of Patients With Major Bleedings in the Presence of Factor Xa Inhibitor Treatment | Biotech Hunter | Biotech Hunter